Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zimmermann

Showing results (211-220 of 279) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantationBritta Maecker, Thomas Jack, Martin Zimmermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemiaHendrik J M de Jonge, Alida C Weidenaar, Arja Ter Elst, et al.
Hemasphere|June 5, 2023
Hypersensitivity Reactions to Native Anja Möricke, Carmelo Rizzari, Julia Alten, et al.
Leukemia|April 26, 2022
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international studyElad Jacoby, Sara Ghorashian, Britta Vormoor, et al.
Bone Marrow Transplantation|February 7, 2024
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppressionBarbara Meissner, Peter Lang, Peter Bader, et al.
Neuro-Oncology|June 3, 2026
Final report of the SIOP-CNS-GCT II protocol for germinoma-omitting radiotherapy boost is safe in localized disease in complete remission after chemotherapyGabriele Calaminus, Claire Alapetite, Rolf D Kortmann, et al.
Blood|January 28, 2009
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemiaIris H I M Hollink, Marry M van den Heuvel-Eibrink, Martin Zimmermann, et al.
Eclinicalmedicine|December 17, 2024
Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trialEwa Koscielniak, Gustaf Ljungman, Bernarda Kazanowska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2013
Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002Jan Stary, Martin Zimmermann, Myriam Campbell, et al.
The New England Journal of Medicine|April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemiaMartin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.
Pageof 28

Showing results (211-220 of 279) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantationBritta Maecker, Thomas Jack, Martin Zimmermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemiaHendrik J M de Jonge, Alida C Weidenaar, Arja Ter Elst, et al.
Hemasphere|June 5, 2023
Hypersensitivity Reactions to Native Anja Möricke, Carmelo Rizzari, Julia Alten, et al.
Leukemia|April 26, 2022
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international studyElad Jacoby, Sara Ghorashian, Britta Vormoor, et al.
Bone Marrow Transplantation|February 7, 2024
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppressionBarbara Meissner, Peter Lang, Peter Bader, et al.
Neuro-Oncology|June 3, 2026
Final report of the SIOP-CNS-GCT II protocol for germinoma-omitting radiotherapy boost is safe in localized disease in complete remission after chemotherapyGabriele Calaminus, Claire Alapetite, Rolf D Kortmann, et al.
Blood|January 28, 2009
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemiaIris H I M Hollink, Marry M van den Heuvel-Eibrink, Martin Zimmermann, et al.
Eclinicalmedicine|December 17, 2024
Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trialEwa Koscielniak, Gustaf Ljungman, Bernarda Kazanowska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2013
Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002Jan Stary, Martin Zimmermann, Myriam Campbell, et al.
The New England Journal of Medicine|April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemiaMartin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.
Pageof 28